Etanercept: A New Drug for the Treatment of Psoriatic Arthritis

Abstract

Get full access to this article

View all access options for this article.

References

Torre Alonso

J.C.

, Rodriguez Perez

, Arribas Castrillo

J.M.

. Psoriatic arthritis: a clinical, immunological and radiological study of 180 patients. Br J Rheumatol 1991; 30: 245–50.

Gladman

D.D.

, Shuckett

, Russell

. Psoriatic arthritis-an analysis of 220 patients. QJ Med 1987; 62: 127–41.

Gladman

D.D.

, Farewell

V.T.

, Wong

. Mortality studies in psoriatic arthritis: results from a single outpatient center-II: prognostic indicators for death. Arthritis Rheum 1998; 41: 1103–10.

Wong

, Gladman

D.D.

, Husted

. Mortality studies in psoriatic arthritis: results from a single outpatient clinic-I: causes and risk of death. Arthritis Rheum 1997; 40: 1868–72.

Rspinoza

L.R.

, Cuellar

M.L.

Psoriatic arthritis: management. In: Kippel

, Dieppe

, eds. Rheumatology. London: Mosby Year Book Europe Limited, 1994; 3: 33·1–33·6.

Jones

, Crotty

, Brooks

The Psoriatic Arthritis Meta-Analysis Study Group. Psoriatic arthritis: a quantitative overview of therapeutic options.

Br J Rheumatol 1997; 36: 95–9.

Pioro

M.H.

, Cash

J.M.

Treatment of refractory psoriatic arthritis.

Rheum Dis Clin North Am 1995; 21: 129–49.

Clegg

D.O.

, Reda

D.J.

, Mejias

. Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. Arthritis Rheum 1996; 39: 2013–20.

Earr

, Kitas

G.D.

, Waterhouse

. Sulfasalazine in psoriatic arthritis: a double-blind placebo-controlled study. Br J Rheumatol 1990; 29: 46–9.

10.

Cuellar

M.L.

, Espinoza

L.R.

Methotrexate use in psoriasis and psoriatic arthritis.

Rheum Dis Clin North Am 1997; 23: 797–809.

11.

Black

R.L.

, O'Brien

W.M.

, Van Scott

E.J.

. Methotrexate therapy in psoriatic arthritis. JAMA 1964; 189: 743–7.

12.

Willkens

R.E.

, Williams

H.J.

, Ward

J.R.

. Randomized, double-blind, placebo controlled trial of low-dose pulse methotrexate in psoriatic arthritis. Arthritis Rheum 1984; 27: 376–81.

13.

Palit

, Hill

, Capell

H.A.

. A multicentre double-blind comparison of auranofin, intramuscular gold thiomalate, and placebo in patients with psoriatic arthritis. Br J Rheumatol 1990; 29: 280–3.

14.

Moreland

L.W.

, Baumgartner

S.W.

, Schiff

M.H.

. Treatment of rheumatoid arthritis with recombinant human tumor necrosis factor-alpha receptor (p75)-Fc fusion protein. N Engl J Med 1997; 337: 141–47.

15.

Moreland

L.W.

, Schiff

M.H.

, Baumgartner

S.W.

. Etanercept therapy for rheumatoid arthritis. Ann Intern Med 1999; 130: 478–86.

16.

Weichenthal

, Godorr

, Altenhoff

. Effects of whole body UVB irradiation on cytokine production bt peripheral blood mononuclear cells from stage I melanoma patients. Arch Dermatol Res 2000 292: 348–53.

17.

Weinblatt

M.E.

, Moreland

L.W.

, Schiff

M.H.

. Longterm and phase III treatment of DMARD failing rheumatoid arthritis patients with TNF receptor p75 Fc fusion protein (TNF: Fc, Enbrel) [abstract]. Arthritis Rheum 1997; 40(9 suppl): S126.

18.

Lovell

D.J.

, Giannini

E.H.

, Reiff

. Etanercept in children with polyarticular juvenile rheumatoid arthritis. N Engl J Med 2000; 342: 763–9.

19.

Korth-Bradley

J.M.

, Rubin

A.S.

, Hana

R.K.

. The pharmacokinetics of etanercept in healthy volunteers. Ann Pharmacother 2000; 34: 161–4.

20.

Etanercept [package insert]. Seattle WA, Immunex, 2000.

21.

Moreland 1997.

22.

Moreland 1997

23.

Weinblatt 1997.

24.

Murphy

F.T.

, Enzenauer

R.J.

Etanercept-associated injection site reactions.

Arch Dermatol 2000; 136: 556–7.

25.

Brion

P.H.

, Mittal-Henkle

, Kalunian

K.C.

. Autoimmune skin rashes associated with etanercept for rheumatoid arthritis. Ann Intern Med 1999; 131: 634.